Page 2 - Boston Medical Center

Oncology & Cancer

Study provides new look at why rare cancer often evades treatments

Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often ...

page 2 from 12